@FiercePharma: Merck is a champion donor, charity pub says. Ranks 2nd for corporate giving, as % of pretax profits.--Forbes. More | Follow @FiercePharma
> European regulators recommended approving Teva Pharmaceutical Industries' ($TEVA) biosimilar version of the Novartis ($NVS) cancer drug Glivec. Report
> India's Dr. Reddy's plans to pay $36 million to buy the Dutch injectables drug firm OctoPlus. Report
> Bayer said its Xarelto blood thinner won European committee backing for a new use in treating pulmonary embolism and for preventing recurrent deep vein thrombosis. Report
> Astellas Pharma launched the hormone-blocking treatment Gonax for prostate cancer in Japan. Report
> Supernus Pharmaceuticals ($SUPN) won FDA approval for its epilepsy drug Oxtellar XR, its second FDA nod since it went public in May. Report
> Medicare's policies on compounded drugs are coming under scrutiny in the wake of a meningitis outbreak linked to a big compounding pharmacy. Report
@FierceMedDev: Israel's growing medical device industry gains a public stage this week. More | Follow @FierceMedDev
@MarkHFierce: W.L. Gore has the final piece in place for its REDUCE Clinical study, to test a new stroke prevention device. More | Follow @MarkHFierce
@DamianFierce: WuXi AppTec is making a splash in biologics, launching a cGMP plant in China. More | Follow @DamianFierce
> Edwards wins broader FDA approval for Sapien heart valve. More
> Wright takes down knee website after Stryker suit. Story
Biotech News
@FierceBiotech: Researchers seek new pancreatic cancer biomarkers. Item | Follow @FierceBiotech
@JohnCFierce: In case you missed it Friday, my analysis on Q3 venture numbers (good) and top 10 deals of the quarter. Special Report | Follow @JohnCFierce
@RyanMFierce: Quintiles reels in pharma business with IT game changers. More | Follow @RyanMFierce
> Orexigen says FDA nods support for a speedy review of Contrave. More
> Genzyme pays $22.5M upfront to bag Asian rights to Alnylam's hot ATTR program. Report
> Bayer nails promising PhIII results for new PAH contender riociguat. News
CRO News
> Lundbeck seeks partners on Alzheimer's drug after EMA rejection. Item
> Korean group enlists WCCT to spur drug development. More
> WuXi launches China's first GMP-friendly biologics plant. News
> Catalent looks to bridge industry, academia on drug delivery. Article
Biotech IT News
> Pfizer wins popularity contest in social media survey of patients. More
> Quintiles reels in pharma business with IT game changers. Story
> Appistry grabs distribution of MIT-Harvard genome toolkit. Report
> Big Pharma consortium to share cancer trial data. Article
And Finally... A new study found that diet and weight loss didn't prevent heart attacks and other problems in diabetics, but they may cut the number of necessary medications. Report